Advantum Health, Inc.

Advantum Health, Inc. is a provider of specialized Revenue Cycle Management solutions designed to enhance the financial performance of healthcare organizations across the United States. Founded in 1996 and headquartered in Louisville, US, Advantum Health offers services that streamline the financial operations of healthcare providers. The company was established by Martin Denz, Suvarna Buldeo, and Venkat Sharma.

The current CEO is Martin Denz. In June 2016, Fulcrum Equity Partners invested in Advantum Health, marking their most recent funding round. Advantum Health specializes in comprehensive Revenue Cycle Management (RCM) solutions tailored to enhance the financial health of healthcare organizations. Their core offerings include fully-outsourced and custom-tailored services addressing challenges in medical coding, billing, denial management, and eligibility verification.

The expert coders work to maximize payments while implementing proactive denial prevention strategies, thereby reducing accounts receivable (AR) days. Advantum's services also encompass automated payor enrollment, seamless authorization processes, and CMS-compliant auditing, aimed at ensuring clean claims submission and expedited reimbursements. They serve a diverse clientele, including medical groups, therapy rehabilitation facilities, and senior living services across the United States. Advantum Health generates revenue through a structured transaction model that includes partnerships and B2B engagements with healthcare providers.

They offer various RCM services on a contractual basis, allowing for flexible pricing based on tailored solutions provided to each client. Their flagship services in coding and denial management are pivotal in generating revenue, enabling clients to achieve better cash flow and enhance operational efficiency. Advantum Health plans to expand its service offerings by launching new products and enhancing existing solutions aimed at optimizing revenue cycles for healthcare clients. The firm is targeting an expansion into new geographic markets within the United States by the end of 2024.

The funds from the investment secured in June 2016 will be utilized to support these initiatives, allowing for improvements in technology and operational capabilities.